Healthcare provider profile · identity verified

James Meadows, MD

Internal Medicine · LYNCHBURG, VA · NPI 1174506679

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	688	205
Amlodipine Besylate	Amlodipine Besylate	565	163
Omeprazole	Omeprazole	395	113
Montelukast Sodium	Montelukast Sodium	394	101
Lisinopril	Lisinopril	349	103
Levothyroxine Sodium	Levothyroxine Sodium	271	73
Metoprolol Succinate	Metoprolol Succinate	270	75
Pantoprazole Sodium	Pantoprazole Sodium	234	66
Rosuvastatin Calcium	Rosuvastatin Calcium	234	64
Metformin Hcl	Metformin Hcl	228	69
Furosemide	Furosemide	203	63
Carvedilol	Carvedilol	196	59
Hydrochlorothiazide	Hydrochlorothiazide	195	62
Losartan Potassium	Losartan Potassium	191	58
Fluticasone Propionate	Fluticasone Propionate	189	79
Metoprolol Tartrate	Metoprolol Tartrate	189	51
Eliquis	Apixaban	188	44
Famotidine	Famotidine	183	44
Glimepiride	Glimepiride	182	45
Tamsulosin Hcl	Tamsulosin Hcl	178	57
Duloxetine Hcl	Duloxetine Hcl	173	44
Pravastatin Sodium	Pravastatin Sodium	170	54
Valsartan	Valsartan	162	43
Gabapentin	Gabapentin	156	47
Potassium Chloride	Potassium Chloride	153	41
Allopurinol	Allopurinol	152	47
Simvastatin	Simvastatin	148	41
Albuterol Sulfate Hfa	Albuterol Sulfate	147	55
Trazodone Hcl	Trazodone Hcl	137	36
Escitalopram Oxalate	Escitalopram Oxalate	118	30
Ezetimibe	Ezetimibe	116	34
Meloxicam	Meloxicam	113	59
Ozempic	Semaglutide	100	19
Atenolol	Atenolol	97	28
Clopidogrel	Clopidogrel Bisulfate	96	22
Sertraline Hcl	Sertraline Hcl	90	29
Hydralazine Hcl	Hydralazine Hcl	89	22
Hydroxyzine Hcl	Hydroxyzine Hcl	86	28
Metformin Hcl Er	Metformin Hcl	85	28
Jardiance	Empagliflozin	84	18
Diclofenac Sodium	Diclofenac Sodium	83	38
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	82	27
Spironolactone	Spironolactone	73	19
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	70	22
Alendronate Sodium	Alendronate Sodium	68	21
Isosorbide Mononitrate Er	Isosorbide Mononitrate	68	17
Prednisone	Prednisone	61	44
Donepezil Hcl	Donepezil Hcl	58	16
Ipratropium Bromide	Ipratropium Bromide	58	18
Torsemide	Torsemide	58	16
Bupropion Xl	Bupropion Hcl	56	16
Mirtazapine	Mirtazapine	53	17
Tramadol Hcl	Tramadol Hcl	50	17
Nifedipine Er	Nifedipine	47	11
Amitriptyline Hcl	Amitriptyline Hcl	46	14
Celecoxib	Celecoxib	46	suppressed
Nystatin	Nystatin	46	23
Ramipril	Ramipril	46	13
Lovastatin	Lovastatin	45	12
Xarelto	Rivaroxaban	45	16
Esomeprazole Magnesium	Esomeprazole Magnesium	41	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	40	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	37	suppressed
Finasteride	Finasteride	37	13
Triamcinolone Acetonide	Triamcinolone Acetonide	37	21
Citalopram Hbr	Citalopram Hydrobromide	36	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	36	13
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	34	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	34	suppressed
Pregabalin	Pregabalin	33	suppressed
Solifenacin Succinate	Solifenacin Succinate	33	suppressed
Ondansetron Hcl	Ondansetron Hcl	32	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	31	suppressed
Benazepril Hcl	Benazepril Hcl	30	suppressed
Colchicine	Colchicine	30	12
Oxybutynin Chloride Er	Oxybutynin Chloride	30	12
Symbicort	Budesonide/Formoterol Fumarate	29	suppressed
Synthroid	Levothyroxine Sodium	29	suppressed
Cephalexin	Cephalexin	28	27
Ropinirole Hcl	Ropinirole Hcl	27	suppressed
Farxiga	Dapagliflozin Propanediol	26	suppressed
Testosterone	Testosterone	26	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	25	suppressed
Mounjaro	Tirzepatide	24	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	24	suppressed
Terazosin Hcl	Terazosin Hcl	24	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	22	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	22	19
Bupropion Hcl Sr	Bupropion Hcl	21	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	21	21
Enalapril Maleate	Enalapril Maleate	21	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	21	suppressed
Clonidine Hcl	Clonidine Hcl	20	suppressed
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Entresto	Sacubitril/Valsartan	19	suppressed
Januvia	Sitagliptin Phosphate	19	suppressed
Amoxicillin	Amoxicillin	18	17
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	18	suppressed
Glipizide	Glipizide	18	suppressed
Meclizine Hcl	Meclizine Hcl	18	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	18	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	17	suppressed
Fenofibrate	Fenofibrate	16	suppressed
Humalog Kwikpen U-200	Insulin Lispro	16	suppressed
Irbesartan	Irbesartan	16	suppressed
Ketoconazole	Ketoconazole	16	suppressed
Nebivolol Hcl	Nebivolol Hcl	16	suppressed
Tizanidine Hcl	Tizanidine Hcl	16	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	16	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	15	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	15	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	15	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	15	suppressed
Memantine Hcl	Memantine Hcl	15	suppressed
Novolog Flexpen	Insulin Aspart	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Dexlansoprazole Dr	Dexlansoprazole	14	suppressed
Timolol Maleate	Timolol Maleate	14	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	14	suppressed
Warfarin Sodium	Warfarin Sodium	14	suppressed
Azelastine Hcl	Azelastine Hcl	13	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	13	suppressed
Dutasteride	Dutasteride	13	suppressed
Lactulose	Lactulose	13	suppressed
Lansoprazole	Lansoprazole	13	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Levemir Flexpen	Insulin Detemir	13	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	13	suppressed
Potassium Citrate Er	Potassium Citrate	13	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	12	suppressed
Linzess	Linaclotide	12	suppressed
Loperamide	Loperamide Hcl	12	suppressed
Trospium Chloride Er	Trospium Chloride	12	suppressed
Alprazolam	Alprazolam	11	suppressed
Azelastine-Fluticasone	Azelastine/Fluticasone	11	suppressed
Lidocaine	Lidocaine	11	suppressed
Midodrine Hcl	Midodrine Hcl	11	suppressed
Olanzapine	Olanzapine	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error